Study Compares Newly Approved Drugs for Prevention
of Kidney Cancer Recurrence (Cancer Coming Back) -->
Advanced cases of kidney cancer often require more than surgery alone to achieve the best long-term results.
Fox Chase Cancer Center is a leading hospital for participation in kidney cancer treatment clinical trials.
Medical oncologists at Fox Chase are nationally recognized for their experience in caring for kidney cancer patients who are not completely treated by surgery alone. They are also nationally recognized for their contributions in the development of the newest medicines that have proven to be effective in treating advanced and metastatic kidney cancer (cancer that has spread to other parts of the body).
Radiation for Kidney Cancer
Fox Chase Cancer Center is a national leader in the use of radiation therapy to treat patients with many different types of cancer. Our radiation treatment technology is among the most sophisticated in the world. While radiation therapy is rarely used as a primary treatment for kidney cancer, external beam radiation treatment can be used for palliative therapy and for effective relief of pain or other symptoms in patients with advanced kidney cancer that has spread to the bones or other locations.
Active Surveillance
(Formerly Known as "Watchful Waiting")
At Fox Chase Cancer Center, we recognize each patient with kidney cancer is not the same. As a result, not all patients with kidney cancer are treated the same and not all patients will require or benefit from surgery.
Fox Chase Cancer Center doctors have the world's largest published experience with active surveillance of kidney cancer and have identified tumor growth kinetics (how fast the tumor is growing) as one means of determining who is a candidate for active surveillance and identifying patients who might safely avoid or defer surgery.
Optimized Treatment for Advanced Kidney Cancer
Our medical oncologists have been pivotal in the development of new medications, as new therapies for patients with advanced and metastatic kidney cancer.
National Leaders in
Kidney Cancer Research
Fox Chase doctors are national leaders in kidney cancer (renal cancer) research. Their work appears in the world's leading academic papers, academic journals, journals and books.
Ongoing research at Fox Chase Cancer Center continues to develop and refine these approaches and drug combinations. Newer approaches include:
Boosting the body's own immune system to combat the disease, since conventional kidney cancer chemotherapy has shown only marginal response
"Targeted" therapies, which focus on interfering with a cancer's ability to stimulate its own growth and proliferation
See National Cancer Institute information on
Kidney Cancer Support Group
group for individuals diagnosed with kidney cancer where members meet monthly to share information and support. Read more »
Find a Clinical Trial
Benefit from new cancer treatments
Read more »
|